• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年龄相关的 C9orf72 重复扩展的外显率。

Age-related penetrance of the C9orf72 repeat expansion.

机构信息

Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, 20892, USA.

Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, 18509, USA.

出版信息

Sci Rep. 2017 May 18;7(1):2116. doi: 10.1038/s41598-017-02364-1.

DOI:10.1038/s41598-017-02364-1
PMID:28522837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5437033/
Abstract

A pathogenic hexanucleotide repeat expansion within the C9orf72 gene has been identified as the major cause of two neurodegenerative syndromes, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This mutation is known to have incomplete penetrance, with some patients developing disease in their twenties and a small portion of carriers surviving to their ninth decade without developing symptoms. Describing penetrance by age among C9orf72 carriers and identifying parameters that alter onset age are essential to better understanding this locus and to enhance predictive counseling. To do so, data from 1,170 individuals were used to model penetrance. Our analysis showed that the penetrance was incomplete and age-dependent. Additionally, familial and sporadic penetrance did not significantly differ from one another; ALS cases exhibited earlier age of onset than FTD cases; and individuals with spinal-onset exhibited earlier age of onset than those with bulbar-onset. The older age of onset among female cases in general, and among female bulbar-onset cases in particular, was the most striking finding, and there may be an environmental, lifestyle, or hormonal factor that is influencing these penetrance patterns. These results will have important applications for future clinical research, the identification of disease modifiers, and genetic counseling.

摘要

C9orf72 基因内的致病性六核苷酸重复扩展已被确定为两种神经退行性综合征肌萎缩侧索硬化症 (ALS) 和额颞叶痴呆 (FTD) 的主要病因。这种突变的外显率不完全,一些患者在二十多岁时就会发病,而一小部分携带者在没有出现症状的情况下可以存活到九十多岁。描述 C9orf72 携带者的年龄外显率并确定改变发病年龄的参数对于更好地了解该基因座并增强预测性咨询至关重要。为此,使用来自 1170 个人的数据来对外显率进行建模。我们的分析表明,外显率不完全且依赖于年龄。此外,家族性和散发性外显率彼此之间没有显着差异;ALS 病例的发病年龄早于 FTD 病例;且脊髓发病的个体比延髓发病的个体发病年龄更早。一般来说女性病例以及特别是女性延髓发病病例的发病年龄较大是最显著的发现,可能存在影响这些外显率模式的环境、生活方式或激素因素。这些结果将对未来的临床研究、疾病修饰因子的识别和遗传咨询具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/9a8788a57965/41598_2017_2364_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/f7624a1bf0d4/41598_2017_2364_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/06502138f872/41598_2017_2364_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/f9a8abf82300/41598_2017_2364_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/9a8788a57965/41598_2017_2364_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/f7624a1bf0d4/41598_2017_2364_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/06502138f872/41598_2017_2364_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/f9a8abf82300/41598_2017_2364_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c168/5437033/9a8788a57965/41598_2017_2364_Fig4_HTML.jpg

相似文献

1
Age-related penetrance of the C9orf72 repeat expansion.与年龄相关的 C9orf72 重复扩展的外显率。
Sci Rep. 2017 May 18;7(1):2116. doi: 10.1038/s41598-017-02364-1.
2
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.C9orf72 六核苷酸重复扩展在肌萎缩侧索硬化症和额颞叶痴呆患者中的频率:一项横断面研究。
Lancet Neurol. 2012 Apr;11(4):323-30. doi: 10.1016/S1474-4422(12)70043-1. Epub 2012 Mar 9.
3
[Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].C9orf72对日本肌萎缩侧索硬化症(ALS)/额颞叶痴呆(FTD)患者的影响
Brain Nerve. 2019 Nov;71(11):1190-1208. doi: 10.11477/mf.1416201429.
4
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.首例意大利 FTD/ALS 家系报道提示 C9orf72 相关:临床异质性与寡基因遗传
J Alzheimers Dis. 2018;62(2):687-697. doi: 10.3233/JAD-170913.
5
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.携带 C9ORF72 基因 GGGGCC 六核苷酸重复扩展的家族性肌萎缩侧索硬化症患者的临床特征。
Brain. 2012 Mar;135(Pt 3):784-93. doi: 10.1093/brain/awr366.
6
The frequency of the C9orf72 expansion in a Brazilian population.巴西人群中 C9orf72 扩展的频率。
Neurobiol Aging. 2018 Jun;66:179.e1-179.e4. doi: 10.1016/j.neurobiolaging.2018.01.007. Epub 2018 Jan 31.
7
Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.希腊额颞叶痴呆队列中C9ORF72重复扩增的筛查。
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):152-154. doi: 10.1080/21678421.2017.1400070. Epub 2017 Nov 23.
8
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.C9ORF72 基因 GGGGCC 重复扩增相关额颞叶痴呆和/或肌萎缩性侧索硬化症的特征。
Brain. 2012 Mar;135(Pt 3):765-83. doi: 10.1093/brain/aws004.
9
Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population.肌萎缩侧索硬化症(ALS)临床患者群体中C9orf72与散发性疾病的对比分析。
Neurology. 2016 Sep 6;87(10):1024-30. doi: 10.1212/WNL.0000000000003067. Epub 2016 Aug 3.
10
Analysis of repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS).对格鲁吉亚肌萎缩侧索硬化症(ALS)患者重复序列扩增的分析。
F1000Res. 2024 Mar 6;12:1113. doi: 10.12688/f1000research.138436.1. eCollection 2023.

引用本文的文献

1
Longitudinal behavioral and neuropsychiatric changes and their MRI correlates in predementia and mutation carriers.痴呆前期和突变携带者的纵向行为及神经精神变化及其MRI相关性
J Alzheimers Dis. 2025 Jun 19;106(3):13872877251350684. doi: 10.1177/13872877251350684.
2
Phenotypical Characterization of C9ALS Patients from the Emilia Romagna Registry of ALS: A Retrospective Case-Control Study.来自艾米利亚-罗马涅肌萎缩侧索硬化症登记处的C9ALS患者的表型特征:一项回顾性病例对照研究。
Genes (Basel). 2025 Mar 4;16(3):309. doi: 10.3390/genes16030309.
3
intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease risk.

本文引用的文献

1
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040.预计 2015 年至 2040 年肌萎缩侧索硬化症的发病率将会增加。
Nat Commun. 2016 Aug 11;7:12408. doi: 10.1038/ncomms12408.
2
Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.C9ORF72 ALS/FTD 相关疾病治疗方法的研发。
Mol Neurobiol. 2017 Aug;54(6):4466-4476. doi: 10.1007/s12035-016-9993-0. Epub 2016 Jun 28.
3
The economic impact of amyotrophic lateral sclerosis: a systematic review.肌萎缩侧索硬化症的经济影响:一项系统综述。
由聚甘氨酸 - 精氨酸病理学鉴定出的内含子扩增增加了阿尔茨海默病风险。
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2416885122. doi: 10.1073/pnas.2416885122. Epub 2025 Feb 12.
4
Clinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的临床特征及诊疗进展
Ann Med. 2024 Dec;56(1):2399962. doi: 10.1080/07853890.2024.2399962. Epub 2024 Dec 3.
5
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers.无症状C9orf72六核苷酸重复扩增携带者脑脊液中泛素羧基末端水解酶同工酶L1升高。
Ann Neurol. 2025 Mar;97(3):449-459. doi: 10.1002/ana.27133. Epub 2024 Nov 16.
6
Longitudinal Magnetic Resonance Imaging in Asymptomatic C9orf72 Mutation Carriers Distinguishes Phenoconverters to Amyotrophic Lateral Sclerosis or Amyotrophic Lateral Sclerosis With Frontotemporal Dementia.无症状C9orf72突变携带者的纵向磁共振成像可区分向肌萎缩侧索硬化症或伴额颞叶痴呆的肌萎缩侧索硬化症的表型转化者。
Ann Neurol. 2025 Feb;97(2):281-295. doi: 10.1002/ana.27116. Epub 2024 Nov 2.
7
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data.利用大规模基因组数据实现 C9orf72 相关 ALS/FTD 药物的无机制重新利用。
Cell Genom. 2024 Nov 13;4(11):100679. doi: 10.1016/j.xgen.2024.100679. Epub 2024 Oct 21.
8
Increased frequency of repeat expansion mutations across different populations.在不同人群中,重复扩展突变的频率增加。
Nat Med. 2024 Nov;30(11):3357-3368. doi: 10.1038/s41591-024-03190-5. Epub 2024 Oct 1.
9
Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances.了解肌萎缩侧索硬化症:病理生理学、诊断和治疗进展。
Int J Mol Sci. 2024 Sep 15;25(18):9966. doi: 10.3390/ijms25189966.
10
Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia.C9orf72相关肌萎缩侧索硬化症和额颞叶痴呆的个性化外显率估计
BMJ Neurol Open. 2024 Sep 18;6(2):e000792. doi: 10.1136/bmjno-2024-000792. eCollection 2024.
Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):439-50. doi: 10.1586/14737167.2015.1039941. Epub 2015 Apr 30.
4
Clinical and genetic heterogeneity of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的临床和遗传异质性。
Clin Genet. 2013 May;83(5):408-16. doi: 10.1111/cge.12117. Epub 2013 Mar 12.
5
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.C9ORF72 重复扩增与额颞叶痴呆疾病谱:基因检测流程图。
J Alzheimers Dis. 2013;34(2):485-99. doi: 10.3233/JAD-121456.
6
Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study.散发型肌萎缩侧索硬化症中C9orf72六核苷酸重复序列扩增的传递:一项澳大利亚三人组研究。
Neuroreport. 2012 Jun 20;23(9):556-9. doi: 10.1097/WNR.0b013e3283544718.
7
High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients.在希腊家族性和散发性 ALS 患者中,C9ORF72 六核苷酸重复扩展的高频率。
Neurobiol Aging. 2012 Aug;33(8):1851.e1-5. doi: 10.1016/j.neurobiolaging.2012.02.021. Epub 2012 Mar 22.
8
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.C9orf72 六核苷酸重复扩展在肌萎缩侧索硬化症和额颞叶痴呆患者中的频率:一项横断面研究。
Lancet Neurol. 2012 Apr;11(4):323-30. doi: 10.1016/S1474-4422(12)70043-1. Epub 2012 Mar 9.
9
Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.伴有 C9ORF72 基因扩增的肌萎缩侧索硬化症的临床病理特征。
Brain. 2012 Mar;135(Pt 3):751-64. doi: 10.1093/brain/awr365.
10
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.C9ORF72 上的六核苷酸重复扩展是 9p21 连锁 ALS-FTD 的原因。
Neuron. 2011 Oct 20;72(2):257-68. doi: 10.1016/j.neuron.2011.09.010. Epub 2011 Sep 21.